Discordance in Creatinine- and Cystatin C–Based eGFR and Clinical Outcomes: A Meta-Analysis

医学 胱抑素C 内科学 门诊就诊 肿瘤科 肾功能 门诊部 肾 梅德林 回顾性队列研究 门诊手术
作者
Michelle M. Estrella,Shoshana H. Ballew,Yingying Sang,Morgan Erika Grams,Josef Coresh,Aditya Surapaneni,Natália Alencar de Pinho,Johan Ärnlöv,Hermann Brenner,Juan Jesús Carrero,Teresa K. Chen,Debbie L. Cohen,Mary Cushman,Ronald T. Gansevoort,Shih‐Jen Hwang,Lesley A. Inker,Joachim H. Ix,Keiko Kabasawa,Tsuneo Konta,Jennifer Susan Lees
出处
期刊:JAMA [American Medical Association]
卷期号:334 (21): 1915-1915 被引量:36
标识
DOI:10.1001/jama.2025.17578
摘要

Importance: Estimated glomerular filtration rates (eGFRs) can differ according to whether creatinine or cystatin C is used for the eGFR calculation, but the prevalence and importance of these differences remain unclear. Objectives: To evaluate the prevalence of a discordance between cystatin C-based eGFR (eGFRcys) and creatinine-based eGFR (eGFRcr), identify characteristics associated with greater discordance, and evaluate associations of discordance with adverse outcomes. Data Sources: Participants in the Chronic Kidney Disease Prognosis Consortium (CKD-PC). Study Selection: Participants with concurrent cystatin C and creatinine measurements and clinical outcome measurement. Data Extraction and Synthesis: Between April 2024 and August 2025, data were synthesized using individual-level meta-analysis. Main Outcomes and Measures: The primary independent measurement was a large negative eGFR difference (eGFRdiff), defined as an eGFRcys that was at least 30% lower than eGFRcr. Secondary (dependent) outcomes included all-cause and cardiovascular mortality, atherosclerotic cardiovascular disease, heart failure, and kidney failure with replacement therapy. Results: A total of 821 327 individuals from 23 outpatient cohorts (mean [SD] age, 59 [12] years; 48% female; 13.5% with diabetes; 40% with hypertension) and 39 639 individuals from 2 inpatient cohorts (mean [SD] age, 67 [16] years; 31% female; 30% with diabetes; 72% with hypertension) were included. Among outpatient participants, 11% had a large negative eGFRdiff (range, 3%-50%). Among inpatients, 35% had a large negative eGFRdiff. Among outpatient participants, at a mean (SD) follow-up of 11 (4) years, a large negative eGFRdiff, compared with an eGFRdiff between -30% and 30%, was associated with higher rates of all-cause mortality (28.4 vs 16.8 per 1000 person-years [PY]; hazard ratio [HR], 1.69 [95% CI, 1.57-1.82]), cardiovascular mortality (6.1 vs 3.8 per 1000 PY; HR, 1.61 [95% CI, 1.48-1.76]), atherosclerotic cardiovascular disease (13.3 vs 9.8 per 1000 PY; HR, 1.35 [95% CI, 1.27-1.44]), heart failure (13.2 vs 8.6 per 1000 PY; HR, 1.54 [95% CI, 1.40-1.68]), and kidney failure with replacement therapy (2.7 vs 2.1 per 1000 PY; HR, 1.29 [95% CI, 1.13-1.47]). Conclusions and Relevance: In the CKD-PC, 11% of outpatient participants and 35% of hospitalized patients had an eGFRcys that was at least 30% lower than their eGFRcr. In the outpatient setting, presence of eGFRcys at least 30% lower than eGFRcr was associated with significantly higher rates of all-cause mortality, cardiovascular events, and kidney failure.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
chenying完成签到 ,获得积分0
1秒前
shuang完成签到,获得积分10
2秒前
2秒前
我就是KKKK完成签到,获得积分10
3秒前
gsxgg完成签到,获得积分10
5秒前
8秒前
快乐的小木虫完成签到,获得积分10
8秒前
csy完成签到,获得积分10
9秒前
fangyuan完成签到,获得积分10
10秒前
郑琦敏钰完成签到 ,获得积分10
11秒前
davyean完成签到,获得积分10
11秒前
aaa完成签到,获得积分10
11秒前
淡淡依霜完成签到 ,获得积分10
13秒前
辣条我有呀完成签到 ,获得积分10
13秒前
jiangsi完成签到 ,获得积分10
14秒前
酷炫的大碗完成签到,获得积分10
14秒前
Daisy完成签到 ,获得积分10
15秒前
执着的天使完成签到 ,获得积分10
16秒前
生动的乐曲完成签到,获得积分10
16秒前
ChengYonghui完成签到,获得积分10
17秒前
火星上蜜粉完成签到,获得积分10
18秒前
树妖三三完成签到,获得积分10
19秒前
19秒前
crab完成签到,获得积分10
20秒前
厉奕欣完成签到 ,获得积分10
21秒前
QwQ完成签到 ,获得积分10
24秒前
SSY发布了新的文献求助10
24秒前
Wei发布了新的文献求助20
27秒前
Orange的应助被酷酷的怀莲采纳,获得10
31秒前
33秒前
xfy的应助被科研通管家采纳,获得10
33秒前
淡然雁梅完成签到 ,获得积分10
34秒前
ri_290完成签到,获得积分10
35秒前
35秒前
xzcx完成签到 ,获得积分10
35秒前
方方完成签到,获得积分10
36秒前
心如止水完成签到,获得积分10
38秒前
SCINEXUS完成签到,获得积分0
38秒前
怡然绯完成签到 ,获得积分10
39秒前
书生完成签到,获得积分10
43秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166556
求助须知:如何正确求助?哪些是违规求助? 9559576
关于积分的说明 21750809
捐赠科研通 7757392
什么是DOI,文献DOI怎么找? 3429167
关于科研通互助平台的介绍 2553530
邀请新用户注册赠送积分活动 2473923